These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 21729974)

  • 21. [Effects of botulinum toxin guided by electric stimulation on spasticity in ankle plantar flexor of children with cerebral palsy: a randomized trial].
    Xu KS; Yan TB; Mai JN
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):913-7. PubMed ID: 17254459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
    Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
    Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meaningful improvement in walking performance after Botulinum neurotoxin A (BoNT-A) in chronic spastic patients.
    Cioncoloni D; Taddei S; Bielli S; Annunziata P; Mazzocchio R
    NeuroRehabilitation; 2014; 34(1):185-92. PubMed ID: 24284465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined Effects of Isokinetic Training and Botulinum Toxin Type A on Spastic Equinus Foot in Patients with Chronic Stroke: A Pilot, Single-blind, Randomized Controlled Trial.
    Cinone N; Letizia S; Santoro L; Facciorusso S; Armiento R; Picelli A; Ranieri M; Santamato A
    Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30965599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Casting Protocols Following BoNT-A Injections to Treat Spastic Hypertonia of the Triceps Surae in Children with Cerebral Palsy and Equinus Gait: A Randomized Controlled Trial.
    Kelly B; MacKay-Lyons M; Berryman S; Hyndman J; Wood E
    Phys Occup Ther Pediatr; 2019; 39(1):77-93. PubMed ID: 29771161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
    Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
    J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
    Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
    Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study.
    Frasson E; Dall'ora E; Bordignon M; Brigo F; Tocco P; Primon D; Didonè G; Vicentini S; Fiaschi A; Bertolasi L
    J Child Neurol; 2012 May; 27(5):587-93. PubMed ID: 22114218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity.
    Kong KH; Neo JJ; Chua KS
    Clin Rehabil; 2007 Jan; 21(1):28-35. PubMed ID: 17213238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial.
    Corry IS; Cosgrove AP; Duffy CM; McNeill S; Taylor TC; Graham HK
    J Pediatr Orthop; 1998; 18(3):304-11. PubMed ID: 9600553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
    Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
    Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of botulinum toxin A therapy with electrical stimulation on spastic calf muscles in children with cerebral palsy.
    Kang BS; Bang MS; Jung SH
    Am J Phys Med Rehabil; 2007 Nov; 86(11):901-6. PubMed ID: 17873826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy.
    Yap R; Majnemer A; Benaroch T; Cantin MA
    Dev Med Child Neurol; 2010 Feb; 52(2):186-93. PubMed ID: 20412253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized controlled study of the efficacy of the injection of botulinum toxin type A versus corticosteroids in chronic plantar fasciitis: results at one and six months.
    Díaz-Llopis IV; Rodríguez-Ruíz CM; Mulet-Perry S; Mondéjar-Gómez FJ; Climent-Barberá JM; Cholbi-Llobel F
    Clin Rehabil; 2012 Jul; 26(7):594-606. PubMed ID: 22144721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature.
    Picelli A; Santamato A; Chemello E; Cinone N; Cisari C; Gandolfi M; Ranieri M; Smania N; Baricich A
    Ann Phys Rehabil Med; 2019 Jul; 62(4):291-296. PubMed ID: 30219307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury.
    Fock J; Galea MP; Stillman BC; Rawicki B; Clark M
    Brain Inj; 2004 Jan; 18(1):57-63. PubMed ID: 14660236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
    Lam K; Lau KK; So KK; Tam CK; Wu YM; Cheung G; Liang KS; Yeung KM; Lam KY; Yui S; Leung C
    J Am Med Dir Assoc; 2012 Jun; 13(5):477-84. PubMed ID: 22521630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin A in the treatment of hemiplegic spastic foot drop--clinical and functional outcomes.
    Chua KS; Kong KH; Lui YC
    Singapore Med J; 2000 May; 41(5):209-13. PubMed ID: 11063169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts.
    Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is spastic muscle echo intensity related to the response to botulinum toxin type A in patients with stroke? A cohort study.
    Picelli A; Bonetti P; Fontana C; Barausse M; Dambruoso F; Gajofatto F; Girardi P; Manca M; Gimigliano R; Smania N
    Arch Phys Med Rehabil; 2012 Jul; 93(7):1253-8. PubMed ID: 22502807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.